Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Human CaMKII alpha ELISA Kit (AC3210)
Cat.#: ASET-1799
Specifications
Description Human CaMKII alpha ELISA Kit allows for the in vitro quantitative determination of human CaMKII alpha concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 0.094 ng/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 0.156-10 ng/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1367 Porcine Syndecan-1 ELISA Kit (AC2778) Quantitative inquiry ASET-1415 Mouse nNOS (neuronal) ELISA Kit (AC2826) Quantitative inquiry ASET-2199 Mouse Ghrelin ELISA Kit (AC3610) Quantitative inquiry ASET-1090 Human GLP-1R ELISA Kit (AC2501) Quantitative inquiry ASET-1115 Human AVPR1B ELISA Kit (AC2526) Quantitative inquiry ASET-1532 Rat CaMKII beta ELISA Kit (AC2943) Quantitative inquiry ASET-1240 Human Reelin ELISA Kit (AC2651) Quantitative inquiry ASET-1226 Human Neogenin ELISA Kit (AC2637) Quantitative inquiry ASET-2047 Mouse CaSR ELISA Kit (AC3458) Quantitative inquiry ASET-1654 Rat CDK5 ELISA Kit (AC3065) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket